A Phase 1 Safety and PK Study of IV TP-271
Clinical trial NCT03234738 · COMPLETED
Trial details
- NCT number
- NCT03234738
- Sponsor
- Tetraphase Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2018-01-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.